Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)
12.88
+0.23 (1.82%)
Jul 31, 2026, 3:05 PM CST
SHE:300233 Revenue
Shandong Jincheng Pharmaceutical Group had revenue of 750.42M CNY in the quarter ending March 31, 2026, with 3.95% growth. This brings the company's revenue in the last twelve months to 2.77B, down -12.59% year-over-year. In the year 2025, Shandong Jincheng Pharmaceutical Group had annual revenue of 2.74B, down -18.87%.
Revenue (ttm)
2.77B
Revenue Growth
-12.59%
P/S Ratio
1.77
Revenue / Employee
786.75K
Employees
3,515
Market Cap
4.89B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.74B | -636.46M | -18.87% |
| Dec 31, 2024 | 3.37B | -164.93M | -4.66% |
| Dec 31, 2023 | 3.54B | 32.60M | 0.93% |
| Jan 1, 2023 | 3.51B | 367.26M | 11.70% |
| Jan 1, 2022 | 3.14B | 176.52M | 5.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guangdong Yussen Energy Technology | 8.51B |
| Jiangsu Huaxicun | 3.59B |
| Shandong Fengyuan Chemical | 3.34B |
| Shandong Taihe Technologies | 2.89B |
| Hongbaoli Group Corporation | 2.88B |
| Nanjing COSMOS Chemical | 1.58B |
| Guizhou Zhenhua E-chem | 1.34B |
| ABA Chemicals | 1.30B |